Chronic heart failure mainly occurs in older people. The drug therapy options available today represent a decisive advance in treatment options. According to current ESC guideline recommendations, it is advisable to implement the “Fantastic Four” (beta-blockers, SGLT-2-i, ACE-i or ARNI and MRA) quickly, as this is associated with a survival benefit, can slow down the progression of heart failure and help patients to achieve a better quality of life.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- IBDmatters - Advanced Therapeutic Treatments
Examinations and considerations before therapy
- Journal Club
Management of axial spondyloarthritis
- Multiple myeloma
DREAMM-7: Belamaf plus bortezomib and dexamethasone outperforms comparator therapy
- COPD
Better outcomes through patient education and integrated care
- Interview
“Wearables are increasingly accepted as an aid”
- Exogenous allergic alveolitis
Recommendations for therapy for the first time
- Kidney cancer
Urine test could halve the number of postoperative kidney cancer scans
- Evidence, potential and limits